Jean‐Pierre Vilque

1.5k total citations
18 papers, 254 citations indexed

About

Jean‐Pierre Vilque is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Jean‐Pierre Vilque has authored 18 papers receiving a total of 254 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 5 papers in Genetics and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Jean‐Pierre Vilque's work include Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Acute Myeloid Leukemia Research (3 papers). Jean‐Pierre Vilque is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Acute Myeloid Leukemia Research (3 papers). Jean‐Pierre Vilque collaborates with scholars based in France, Switzerland and Luxembourg. Jean‐Pierre Vilque's co-authors include Anne‐Claire Gac, Éric Deconinck, Ghandi Damaj, Philippe Casassus, Denis Guyotat, François Guilhot, Bruno Lioure, B. Audhuy, Sylvain Chantepie and Jean‐Luc Harousseau and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Scientific Reports.

In The Last Decade

Jean‐Pierre Vilque

18 papers receiving 248 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean‐Pierre Vilque France 10 126 78 72 45 41 18 254
Jodi V. Mones United States 8 90 0.7× 103 1.3× 25 0.3× 41 0.9× 25 0.6× 21 283
Ingrid Vášová Czechia 7 153 1.2× 30 0.4× 192 2.7× 59 1.3× 35 0.9× 35 293
Barbara Sosnowska‐Pasiarska Poland 8 94 0.7× 27 0.3× 31 0.4× 22 0.5× 16 0.4× 18 201
H Seifert Switzerland 5 28 0.2× 41 0.5× 54 0.8× 50 1.1× 34 0.8× 7 307
Avyakta Kallam United States 9 104 0.8× 27 0.3× 102 1.4× 66 1.5× 19 0.5× 52 249
Mohamed Touati Morocco 10 74 0.6× 54 0.7× 78 1.1× 69 1.5× 15 0.4× 46 316
Güner Hayri Özsan Türkiye 9 84 0.7× 92 1.2× 53 0.7× 35 0.8× 9 0.2× 34 229
Granada Perea Spain 8 74 0.6× 109 1.4× 91 1.3× 51 1.1× 4 0.1× 12 278
Anna Christoforidou Greece 10 52 0.4× 100 1.3× 15 0.2× 55 1.2× 9 0.2× 29 227
Konstantinos Christofyllakis Germany 6 64 0.5× 26 0.3× 45 0.6× 11 0.2× 13 0.3× 30 149

Countries citing papers authored by Jean‐Pierre Vilque

Since Specialization
Citations

This map shows the geographic impact of Jean‐Pierre Vilque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Pierre Vilque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Pierre Vilque more than expected).

Fields of papers citing papers by Jean‐Pierre Vilque

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Pierre Vilque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Pierre Vilque. The network helps show where Jean‐Pierre Vilque may publish in the future.

Co-authorship network of co-authors of Jean‐Pierre Vilque

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Pierre Vilque. A scholar is included among the top collaborators of Jean‐Pierre Vilque based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Pierre Vilque. Jean‐Pierre Vilque is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Aide, Nicolas, et al.. (2021). Diagnostic value of baseline 18FDG PET/CT skeletal textural features in follicular lymphoma. Scientific Reports. 11(1). 23812–23812. 14 indexed citations
2.
3.
Damaj, Gandhi, et al.. (2021). End-of-treatment 18F-FDG PET/CT in diffuse large B cell lymphoma patients: ΔSUV outperforms Deauville score. Leukemia & lymphoma. 62(12). 2890–2898. 7 indexed citations
4.
Alexandre, Joachim, Joe‐Elie Salem, Javid J. Moslehi, et al.. (2020). Identification of anticancer drugs associated with atrial fibrillation: analysis of the WHO pharmacovigilance database. European Heart Journal - Cardiovascular Pharmacotherapy. 7(4). 312–320. 42 indexed citations
5.
Chantepie, Sylvain, Stéphane Guillouet, Jean‐Pierre Pelage, et al.. (2018). 18F-Fludarabine PET for Lymphoma Imaging: First-in-Humans Study on DLBCL and CLL Patients. Journal of Nuclear Medicine. 59(9). 1380–1385. 15 indexed citations
6.
Gac, Anne‐Claire, Véronique Salaün, Oumédaly Reman, et al.. (2017). Increased frequencies of circulating and tumor-resident Vδ1+T cells in patients with diffuse large B-cell lymphoma. Leukemia & lymphoma. 59(1). 187–195. 17 indexed citations
7.
Dartigeas, Caroline, Eric Van Den Neste, Hervé Maisonneuve, et al.. (2016). Rituximab maintenance after induction with abbreviated FCR in previously untreated elderly (≥ 65 years) CLL patients: Results of the randomized CLL 2007 SA trial from the French FILO Group (NCT00645606).. Journal of Clinical Oncology. 34(15_suppl). 7505–7505. 5 indexed citations
8.
Chantepie, Sylvain, Jean‐Jacques Parienti, Véronique Salaün, et al.. (2016). The prognostic value of hematogones in patients with acute myeloid leukemia. American Journal of Hematology. 91(6). 566–570. 5 indexed citations
9.
Chantepie, Sylvain, Jean-Baptiste Méar, Lydia Guittet, et al.. (2015). Transfusion strategy in hematological intensive care unit: study protocol for a randomized controlled trial. Trials. 16(1). 533–533. 9 indexed citations
10.
Chantepie, Sylvain, Jean-Baptiste Méar, Anne‐Claire Gac, et al.. (2014). Gemtuzumab ozogamicin in combination with intensive chemotherapy in relapsed or refractory acute myeloid leukemia. Leukemia & lymphoma. 56(8). 2326–2330. 13 indexed citations
11.
Gressin, Rémy, Sylvie Caulet-Maugendre, Éric Deconinck, et al.. (2010). Evaluation of the (R)VAD+C regimen for the treatment of newly diagnosed mantle cell lymphoma. Combined results of two prospective phase II trials from the French GOELAMS group. Haematologica. 95(8). 1350–1357. 29 indexed citations
12.
Chamorey, Emmanuel, Rémy Gressin, Frédéric Peyrade, et al.. (2005). Prospective Randomized Study Comparing MEMID with a Chop-Like Regimen in Elderly Patients with Aggressive Non-Hodgkin’s Lymphoma. Oncology. 69(1). 19–26. 4 indexed citations
13.
Millot, Frédéric, Pauline Brice, Noël Philippe, et al.. (2002). α-Interferon in Combination With Cytarabine in Children With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia. Journal of Pediatric Hematology/Oncology. 24(1). 18–22. 11 indexed citations
14.
Harousseau, Jean‐Luc, Brigitte Witz, Bruno Lioure, et al.. (2000). Granulocyte Colony-Stimulating Factor After Intensive Consolidation Chemotherapy in Acute Myeloid Leukemia: Results of a Randomized Trial of the Groupe Ouest-Est Leucémies Aigues Myeloblastiques. Journal of Clinical Oncology. 18(4). 780–780. 56 indexed citations
15.
Jaussaud, R., et al.. (1999). [Normolipemic plane xanthomas and non-Hodgkins malignant lymphomas].. PubMed. 150(2). 162–3. 2 indexed citations
16.
Léone, J., Jean‐Pierre Vilque, B. Pignon, et al.. (1996). Avascular necrosis of the femoral head as a complication of chronic myelogenous leukaemia. Skeletal Radiology. 25(7). 696–698. 12 indexed citations
17.
Pignon, B., Hamid Morjani, Jean‐Pierre Vilque, et al.. (1995). In vitro study of THP-doxorubicin retention in human leukemic cells using confocal laser microspectrofluorometry.. PubMed. 9(8). 1361–7. 6 indexed citations
18.
Pignon, B., et al.. (1990). Evaluation of the efficacy of prophylactic intravenous antibiotherapy with ceftriaxone in post-chemotherapy agranulocytic patients.. PubMed. 32(4). 249–52. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jodi V. Mones Breakdown of academic impact, for papers by Ingrid Vášová Breakdown of academic impact, for papers by Barbara Sosnowska‐Pasiarska Breakdown of academic impact, for papers by H Seifert Breakdown of academic impact, for papers by Avyakta Kallam Breakdown of academic impact, for papers by Mohamed Touati Breakdown of academic impact, for papers by Güner Hayri Özsan Breakdown of academic impact, for papers by Granada Perea Breakdown of academic impact, for papers by Anna Christoforidou Breakdown of academic impact, for papers by Konstantinos Christofyllakis
Rankless by CCL
2026